These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 5302427)

  • 1. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO; Rodhain J
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of benziodarone on hyperuricemia in gout].
    Cottet J; Vittu C
    Presse Med (1893); 1967 May; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperuricemia with benziodarone].
    Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
    Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A
    Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benziodarone in the treatment of hyperuricemia].
    Ravera M
    Clin Ter; 1970 Mar; 52(5):407-16. PubMed ID: 5421984
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of L2214 in the treatment of gout or of rheumatologic syndromes associated with hyperuricemia].
    van Bogaert P
    J Belge Rhumatol Med Phys; 1969; 24(6):295-315. PubMed ID: 5403086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of benziodarone on hyperuricemia].
    Josef H; Cossermelli W; Debes AC; Kopersztych S
    AMB Rev Assoc Med Bras; 1969 Sep; 15(9):381-2. PubMed ID: 5309746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperuricemia and benziodarone].
    Haddad N; Zamouri A; Naccache S
    Tunis Med; 1973; 51(2):103-4. PubMed ID: 4784400
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R; Pagnan A; Fedele D; Novello M; Crepaldi G
    Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
    [No Abstract]   [Full Text] [Related]  

  • 11. [Benziodarone in hyperuricemia due to renal insufficiency].
    Boine L
    Minerva Med; 1973 Jan; 64(4):157-9. PubMed ID: 4568713
    [No Abstract]   [Full Text] [Related]  

  • 12. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R; Hueber EF
    Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary diseases, hyperuricemia and benziodarone. Personal considerations].
    Veglia L
    Minerva Med; 1974 Oct; 65(72):3795-8. PubMed ID: 4608791
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F; Neuwirth R; Berg G
    Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uric acid clearance related to the use of an antirheumatic non-steroid drug].
    Loizzi P; Carrozzo M; Pipitone V
    Minerva Med; 1973; 64(48):2568-75. PubMed ID: 4542205
    [No Abstract]   [Full Text] [Related]  

  • 16. [The hypouricemic effect of benziodarone].
    Gospodinoff L; Salvini S
    Clin Ter; 1969 Oct; 51(2):153-8. PubMed ID: 5365825
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with benziodarone therapy in gout and hyperuricemic syndrome].
    Jorda V; Vykydal M; Pegrimová E; Bouvenot G
    Beitr Rheumatol; 1972; 18():96-9. PubMed ID: 4649127
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hypo-uricemic action of oral benziodarone].
    Nivet M; Marcovici J; Compagnon P; Laruelle P
    Sem Hop; 1967 Jan; 43(2):135-8. PubMed ID: 4291740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benziodarone in the treatment of primary hyperuricemias].
    Bianco G; Marcolongo R; Carcassi A
    Minerva Med; 1968 Dec; 59(99):5470-81. PubMed ID: 5718835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies with a new hypo-urecemic product].
    Vanslype J
    J Belge Rhumatol Med Phys; 1967; 22(2):61-8. PubMed ID: 6045653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.